FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123178771> ?p ?o ?g. }

• W2123178771 endingPage "216" @default.
• W2123178771 startingPage "212" @default.
• W2123178771 abstract "Background: Relentless chronic pulmonary inflammation is the major contributor to morbidity and mortality in patients with cystic fibrosis (CF). While immunomodulating therapies such as prednisolone and ibuprofen may be beneficial, their use is limited by side effects. Macrolides have immunomodulatory properties and long term use dramatically improves prognosis in diffuse panbronchiolitis, a condition with features in common with the lung disease of CF. Methods: To determine if azithromycin (AZM) improves clinical parameters and reduces inflammation in patients with CF, a 3 month prospective randomised double blind, placebo controlled study of AZM (250 mg/day) was undertaken in adults with CF. Monthly assessment included lung function, weight, and quality of life (QOL). Blood and sputum collection assessed systemic inflammation and changes in bacterial flora. Respiratory exacerbations were treated according to the policy of the CF Unit. Results: Sixty patients were recruited (29 men) of mean (SD) age 27.9 (6.5) years and initial forced expiratory volume in 1 second (FEV₁) 56.6 (22.3)% predicted. FEV₁% and forced vital capacity (FVC)% predicted were maintained in the AZM group while in the placebo group there was a mean (SE) decline of –3.62 (1.78)% (p=0.047) and –5.73 (1.66)% (p=0.001), respectively. Fewer courses of intravenous antibiotics were used in patients on AZM (0.37 <i>v</i> 1.13, p=0.016). Median C reactive protein (CRP) levels declined in the AZM group from 10 to 5.4 mg/ml but remained constant in the placebo group (p<0.001). QOL improved over time in patients on AZM and remained unchanged in those on placebo (p=0.035). Conclusion: AZM in adults with CF significantly improved QOL, reduced CRP levels and the number of respiratory exacerbations, and reduced the rate of decline in lung function. Long term AZM may have a significant impact on morbidity and mortality in patients with CF. Further studies are required to define frequency of dosing and duration of benefit." @default.
• W2123178771 created "2016-06-24" @default.
• W2123178771 creator A5053228479 @default.
• W2123178771 date "2002-03-01" @default.
• W2123178771 modified "2023-10-16" @default.
• W2123178771 title "Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial" @default.
• W2123178771 cites W1958034086 @default.
• W2123178771 cites W1980051104 @default.
• W2123178771 cites W1984298324 @default.
• W2123178771 cites W1987437974 @default.
• W2123178771 cites W2005215822 @default.
• W2123178771 cites W2019690306 @default.
• W2123178771 cites W2038481441 @default.
• W2123178771 cites W2043181225 @default.
• W2123178771 cites W2054702311 @default.
• W2123178771 cites W2069466178 @default.
• W2123178771 cites W2071145662 @default.
• W2123178771 cites W2097667004 @default.
• W2123178771 cites W2098768419 @default.
• W2123178771 cites W2101069585 @default.
• W2123178771 cites W2113930416 @default.
• W2123178771 cites W2128000778 @default.
• W2123178771 cites W2129127053 @default.
• W2123178771 cites W2142766427 @default.
• W2123178771 cites W2158213627 @default.
• W2123178771 cites W2317332612 @default.
• W2123178771 cites W2334460415 @default.
• W2123178771 cites W4253991002 @default.
• W2123178771 doi "https://doi.org/10.1136/thorax.57.3.212" @default.
• W2123178771 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1746273" @default.
• W2123178771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11867823" @default.
• W2123178771 hasPublicationYear "2002" @default.
• W2123178771 type Work @default.
• W2123178771 sameAs 2123178771 @default.
• W2123178771 citedByCount "478" @default.
• W2123178771 countsByYear W21231787712012 @default.
• W2123178771 countsByYear W21231787712013 @default.
• W2123178771 countsByYear W21231787712014 @default.
• W2123178771 countsByYear W21231787712015 @default.
• W2123178771 countsByYear W21231787712016 @default.
• W2123178771 countsByYear W21231787712017 @default.
• W2123178771 countsByYear W21231787712018 @default.
• W2123178771 countsByYear W21231787712019 @default.
• W2123178771 countsByYear W21231787712020 @default.
• W2123178771 countsByYear W21231787712021 @default.
• W2123178771 countsByYear W21231787712022 @default.
• W2123178771 countsByYear W21231787712023 @default.
• W2123178771 crossrefType "journal-article" @default.
• W2123178771 hasAuthorship W2123178771A5053228479 @default.
• W2123178771 hasBestOaLocation W21231787711 @default.
• W2123178771 hasConcept C126322002 @default.
• W2123178771 hasConcept C141071460 @default.
• W2123178771 hasConcept C142724271 @default.
• W2123178771 hasConcept C165637977 @default.
• W2123178771 hasConcept C197934379 @default.
• W2123178771 hasConcept C204787440 @default.
• W2123178771 hasConcept C27081682 @default.
• W2123178771 hasConcept C2776301714 @default.
• W2123178771 hasConcept C2776388485 @default.
• W2123178771 hasConcept C2776914184 @default.
• W2123178771 hasConcept C2776938444 @default.
• W2123178771 hasConcept C2777714996 @default.
• W2123178771 hasConcept C2778907293 @default.
• W2123178771 hasConcept C2780206985 @default.
• W2123178771 hasConcept C2781069245 @default.
• W2123178771 hasConcept C2781195455 @default.
• W2123178771 hasConcept C3018587741 @default.
• W2123178771 hasConcept C501593827 @default.
• W2123178771 hasConcept C55520419 @default.
• W2123178771 hasConcept C71924100 @default.
• W2123178771 hasConcept C75603125 @default.
• W2123178771 hasConcept C86803240 @default.
• W2123178771 hasConcept C89423630 @default.
• W2123178771 hasConcept C90924648 @default.
• W2123178771 hasConceptScore W2123178771C126322002 @default.
• W2123178771 hasConceptScore W2123178771C141071460 @default.
• W2123178771 hasConceptScore W2123178771C142724271 @default.
• W2123178771 hasConceptScore W2123178771C165637977 @default.
• W2123178771 hasConceptScore W2123178771C197934379 @default.
• W2123178771 hasConceptScore W2123178771C204787440 @default.
• W2123178771 hasConceptScore W2123178771C27081682 @default.
• W2123178771 hasConceptScore W2123178771C2776301714 @default.
• W2123178771 hasConceptScore W2123178771C2776388485 @default.
• W2123178771 hasConceptScore W2123178771C2776914184 @default.
• W2123178771 hasConceptScore W2123178771C2776938444 @default.
• W2123178771 hasConceptScore W2123178771C2777714996 @default.
• W2123178771 hasConceptScore W2123178771C2778907293 @default.
• W2123178771 hasConceptScore W2123178771C2780206985 @default.
• W2123178771 hasConceptScore W2123178771C2781069245 @default.
• W2123178771 hasConceptScore W2123178771C2781195455 @default.
• W2123178771 hasConceptScore W2123178771C3018587741 @default.
• W2123178771 hasConceptScore W2123178771C501593827 @default.
• W2123178771 hasConceptScore W2123178771C55520419 @default.
• W2123178771 hasConceptScore W2123178771C71924100 @default.
• W2123178771 hasConceptScore W2123178771C75603125 @default.
• W2123178771 hasConceptScore W2123178771C86803240 @default.
• W2123178771 hasConceptScore W2123178771C89423630 @default.
• W2123178771 hasConceptScore W2123178771C90924648 @default.

• next